Condition: Non-Hodgkin Lymphoma · Hodgkin Lymphoma · Sponsor: Masonic Cancer Center, University of Minnesota
This is a phase II study of autologous transplant for patients with Hodgkin (HL) and non-Hodgkin lymphomas (NHL) including those who are HIV positive.
This description comes directly from the study's public registry record.
Timothy Krepski · 612-273-2800 · tkrepsk1@fairview.org
Always discuss trial participation with your own doctor first.
| Masonic Cancer Center, University of Minnesota | Minneapolis, Minnesota, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03125642